1. Dai, Weiqi, Xu, Ling, Yu, Xiangnan, Guo, Chuanyong, Shen, Xizhong. 2019. OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism. In Journal of hepatology, 72, 909-923. doi:10.1016/j.jhep.2019.12.015. https://pubmed.ncbi.nlm.nih.gov/31899205/
2. Khalaj-Kondori, Mohammad, Hosseinnejad, Mina, Hosseinzadeh, Asghar, Behroz Sharif, Shahin, Hashemzadeh, Shahriar. 2019. Aberrant hypermethylation of OGDHL gene promoter in sporadic colorectal cancer. In Current problems in cancer, 44, 100471. doi:10.1016/j.currproblcancer.2019.03.001. https://pubmed.ncbi.nlm.nih.gov/30904169/
3. Tang, Yaohan, Zhu, Yaoxi, Lu, Yang, Du, Yimei, Yuan, Jing. 2022. The Potential of Metabolism-Related Gene OGDHL as a Biomarker for Myocardial Remodeling in Dilated Cardiomyopathy. In Frontiers in cardiovascular medicine, 9, 741920. doi:10.3389/fcvm.2022.741920. https://pubmed.ncbi.nlm.nih.gov/35463769/
4. Lin, Sheng-Jia, Vona, Barbara, Lau, Tracy, Maroofian, Reza, Varshney, Gaurav K. 2023. Evaluating the association of biallelic OGDHL variants with significant phenotypic heterogeneity. In Genome medicine, 15, 102. doi:10.1186/s13073-023-01258-4. https://pubmed.ncbi.nlm.nih.gov/38031187/
5. Pan, Zhi, Tian, Hongjun, Fang, Tao, Wang, Wenqiang, Zhuo, Chuanjun. 2022. OGDHL Variant rs2293239: A Potential Genetic Driver of Chinese Familial Depressive Disorder. In Frontiers in psychiatry, 13, 771950. doi:10.3389/fpsyt.2022.771950. https://pubmed.ncbi.nlm.nih.gov/35370858/
智鼠故事 
